Haystack Oncology

Who we are

Powered by pioneers in liquid biopsy

Haystack Oncology is based on over 20 years of liquid biopsy technology and clinical development led by the scientists specialized in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease therapy monitoring. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated billions of dollars in enterprise value.

Scientific Founders

HS-grid-items (2)
HS-grid-items (1)

Leadership

Board of Directors

Chairman

Isaac
Ro

Founder & Director

Dr. Nicholas
Papadopoulos

Director

Dan
Edelstein

Director

George C.
Petrocheilos

Director

R. Jacob
Vogelstein

Clinical Scientific Advisors

Haystack Oncology’s clinical advisory board brings a diversity of thought leadership among oncology experts, and is foundational to our mission of providing better MRD testing for better patient outcomes.

News & Events

The Latest

Find out what's happening at Haystack Oncology and stay up-to-date with industry news.